速效救心丸和麝香保心丸治疗冠心病心绞痛的成本-效果分析

Cost-effectiveness Analysis of Suxiao Jiuxin Pill and Shexiang Baoxin Pill for the Treatment of Angina Pectoris

目的比较速效救心丸和麝香保心丸治疗冠心病心绞痛的经济性。方法通过文献综述和meta分析计算速效救心丸和麝香保心丸治疗冠心病心绞痛的有效率;根据发改委、省物价局、卫生系统公布的药品价格和检查价格,计算成本数据;在此基础上基于全社会的角度进行成本-效果分析。结果在确定性分析中,速效救心丸组的总成本低于麝香保心丸组(分别为384.96元和396.70元)、治疗有效率高于麝香保心丸组(分别为88.57%和87.11%);针对文献质量、药品价格、疗程进行敏感性分析,结果基本与确定性分析相一致,但"文献质量"为敏感性因素。结论速效救心丸治疗冠心病心绞痛的经济性总体上优于麝香保心丸,但还需深入研究。

OBJECTIVE To compare the economy of Suxiao Jiuxin pill and Shexiang Baoxin pill in treatment of angina pectoris. METHODS According to the literature review and meta-analysis to calculate the effective rate of Suxiao Jiuxin pill and Shexiang Baoxin pill; and then combine the price from the National Development and Reform Commission, Commodity Prices, health system to perform cost-effectiveness analysis from a social prospective. RESULTS The deterministic study showed that the cost of Suxiao Jiuxin pill was lower than Shexiang Baoxin pill（$384.96 vs $396.70）, and the effective rate of Suxiao Jiuxin pill was higher than Shexiang Baoxin pill（88.57% vs 87.11%）. Sensitivity analysis was robust but the quality of literature was a sensitive factor. CONCLUSION Suxiao Jiuxin pill is better than Shexiang Baoxin pill in treating angina pectoris in terms of the economy, but it still needs further research.